Skip to main content
Erschienen in: Abdominal Radiology 4/2017

28.11.2016

Colorectal cancer staging: comparison of whole-body PET/CT and PET/MR

verfasst von: Onofrio A. Catalano, Artur M. Coutinho, Dushyant V. Sahani, Mark G. Vangel, Michael S. Gee, Peter F. Hahn, Thomas Witzel, Andrea Soricelli, Marco Salvatore, Ciprian Catana, Umar Mahmood, Bruce R. Rosen, Debra Gervais

Erschienen in: Abdominal Radiology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Correct staging is imperative for colorectal cancer (CRC) since it influences both prognosis and management. Several imaging methods are used for this purpose, with variable performance. Positron emission tomography–magnetic resonance (PET/MR) is an innovative imaging technique recently employed for clinical application. The present study was undertaken to compare the staging accuracy of whole-body positron emission tomography–computed tomography (PET/CT) with whole-body PET/MR in patients with both newly diagnosed and treated colorectal cancer.

Methods

Twenty-six patients, who underwent same day whole-body (WB) PET/CT and WB-PET/MR, were evaluated. PET/CT and PET/MR studies were interpreted by consensus by a radiologist and a nuclear medicine physician. Correlations with prior imaging and follow-up studies were used as the reference standard. Correct staging was compared between methods using McNemar’s Chi square test.

Results

The two methods were in agreement and correct for 18/26 (69%) patients, and in agreement and incorrect for one patient (3.8%). PET/MR and PET/CT stages for the remaining 7/26 patients (27%) were discordant, with PET/MR staging being correct in all seven cases. PET/MR significantly outperformed PET/CT overall for accurate staging (P = 0.02).

Conclusion

PET/MR outperformed PET/CT in CRC staging. PET/MR might allow accurate local and distant staging of CRC patients during both at the time of diagnosis and during follow-up.
Literatur
1.
Zurück zum Zitat Howlander N, Noone AM, Krapcho M, et al. (2014) SEER cancer statistics review, 1975–2011. Bethesda: National Cancer Institute Howlander N, Noone AM, Krapcho M, et al. (2014) SEER cancer statistics review, 1975–2011. Bethesda: National Cancer Institute
2.
Zurück zum Zitat U.S. Cancer Working Group (2015) United States Cancer Statistics: 1999–2012 Incidence and Mortality Web-based Report. Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute, Atlanta U.S. Cancer Working Group (2015) United States Cancer Statistics: 1999–2012 Incidence and Mortality Web-based Report. Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute, Atlanta
4.
Zurück zum Zitat Abdalla E, Vauthey J-N, Ellis L, et al. (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818CrossRefPubMedPubMedCentral Abdalla E, Vauthey J-N, Ellis L, et al. (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Kanas G, Taylor A, Primrose J, et al. (2012) Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol 4:283–301PubMedPubMedCentral Kanas G, Taylor A, Primrose J, et al. (2012) Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol 4:283–301PubMedPubMedCentral
6.
Zurück zum Zitat Haug U, Engel S, Verheyen F, Linder R (2014) Estimating colorectal cancer treatment costs: a pragmatic approach exemplified by health insurance data from Germany. Plos ONE 9:e88407CrossRefPubMedPubMedCentral Haug U, Engel S, Verheyen F, Linder R (2014) Estimating colorectal cancer treatment costs: a pragmatic approach exemplified by health insurance data from Germany. Plos ONE 9:e88407CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Nagtegaal ID, Quirke P (2008) What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 26:303–312CrossRefPubMed Nagtegaal ID, Quirke P (2008) What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 26:303–312CrossRefPubMed
8.
Zurück zum Zitat Niekel M, Bipat S, Stoker J (2010) Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 257:674–684CrossRefPubMed Niekel M, Bipat S, Stoker J (2010) Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 257:674–684CrossRefPubMed
9.
Zurück zum Zitat Cohade C, Osman M, Leal J, Wahl R (2003) Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 44:1797–1803PubMed Cohade C, Osman M, Leal J, Wahl R (2003) Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 44:1797–1803PubMed
10.
Zurück zum Zitat Veil-Haibach P, Kuehle CA, Beyer T, et al. (2006) Diagnostic accuracy of colorectal cancer staging with whole-body PET/CT colonography. JAMA 296:2590–2600CrossRef Veil-Haibach P, Kuehle CA, Beyer T, et al. (2006) Diagnostic accuracy of colorectal cancer staging with whole-body PET/CT colonography. JAMA 296:2590–2600CrossRef
11.
Zurück zum Zitat Low R, McCue M, Barone R, Saleh F, Song T (2003) MR staging of primary colorectal carcinoma: comparison with surgical and histopathologic findings. Abdom Imaging 28:784–793CrossRefPubMed Low R, McCue M, Barone R, Saleh F, Song T (2003) MR staging of primary colorectal carcinoma: comparison with surgical and histopathologic findings. Abdom Imaging 28:784–793CrossRefPubMed
12.
Zurück zum Zitat Bipat S, Glas A, Slors F, et al. (2004) Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR Imaging—a meta-analysis. Radiology 232:773–783CrossRefPubMed Bipat S, Glas A, Slors F, et al. (2004) Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR Imaging—a meta-analysis. Radiology 232:773–783CrossRefPubMed
13.
Zurück zum Zitat Fletcher J, Djulbegovic B, Soares H, et al. (2008) Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 49:480–508CrossRefPubMed Fletcher J, Djulbegovic B, Soares H, et al. (2008) Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 49:480–508CrossRefPubMed
14.
Zurück zum Zitat Brush B, Chappell F, et al. (2011) The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation. Health Technol Assess. doi:10.3310/hta15350 PubMedPubMedCentral Brush B, Chappell F, et al. (2011) The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation. Health Technol Assess. doi:10.​3310/​hta15350 PubMedPubMedCentral
15.
Zurück zum Zitat Kwok H, Bisset IP, Hill GL (2000) Preoperative staging of rectal cancer. Int J Colorectal Dis 15:9–20CrossRefPubMed Kwok H, Bisset IP, Hill GL (2000) Preoperative staging of rectal cancer. Int J Colorectal Dis 15:9–20CrossRefPubMed
16.
Zurück zum Zitat Kinkel K, Lu Y, Both M, Warren R, Thoeni R (2002) Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 224:748–756CrossRefPubMed Kinkel K, Lu Y, Both M, Warren R, Thoeni R (2002) Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 224:748–756CrossRefPubMed
18.
Zurück zum Zitat Even-Sapir E, Parag Y, Lerman H, et al. (2004) Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 232:815–822CrossRefPubMed Even-Sapir E, Parag Y, Lerman H, et al. (2004) Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 232:815–822CrossRefPubMed
19.
Zurück zum Zitat Hany TF, Steinert HC, Goerres GW, Buck A, von Schulthess GK (2002) PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology 225:575–581CrossRefPubMed Hany TF, Steinert HC, Goerres GW, Buck A, von Schulthess GK (2002) PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology 225:575–581CrossRefPubMed
20.
Zurück zum Zitat Nie Y, Li Q, Li F, et al. (2006) Integrating PET and CT information to improve diagnostic accuracy for lung nodules: a semiautomatic computer-aided method. J Nucl Med 47:1075–1080PubMed Nie Y, Li Q, Li F, et al. (2006) Integrating PET and CT information to improve diagnostic accuracy for lung nodules: a semiautomatic computer-aided method. J Nucl Med 47:1075–1080PubMed
21.
Zurück zum Zitat Al-Nabhani K, Syed R, Michopoulou S, et al. (2013) Qualitative and quantitative comparison of PET/CT and PET/MR imaging in clinical practice. J Nucl Med 55:88–94CrossRefPubMed Al-Nabhani K, Syed R, Michopoulou S, et al. (2013) Qualitative and quantitative comparison of PET/CT and PET/MR imaging in clinical practice. J Nucl Med 55:88–94CrossRefPubMed
22.
Zurück zum Zitat Kang B, Lee J, Song Y, et al. (2016) Added value of integrated whole-body PET/MRI for evaluation of colorectal cancer: comparison with contrast-enhanced MDCT. Am J Roentgenol 206:W10–W20CrossRef Kang B, Lee J, Song Y, et al. (2016) Added value of integrated whole-body PET/MRI for evaluation of colorectal cancer: comparison with contrast-enhanced MDCT. Am J Roentgenol 206:W10–W20CrossRef
23.
Zurück zum Zitat Catalano OA, Rosen BR, Sahani DV, et al. (2013) Clinical impact of PET/MR imaging in patients with cancer undergoing same-day PET/CT: initial experience in 134 patients—a hypothesis-generating exploratory study. Radiology 269:857–869CrossRefPubMed Catalano OA, Rosen BR, Sahani DV, et al. (2013) Clinical impact of PET/MR imaging in patients with cancer undergoing same-day PET/CT: initial experience in 134 patients—a hypothesis-generating exploratory study. Radiology 269:857–869CrossRefPubMed
24.
Zurück zum Zitat Paspulati R, Partovi S, Herrmann K, et al. (2015) Comparison of hybrid FDG PET/MRI compared with PET/CT in colorectal cancer staging and restaging: a pilot study. Abdom Imaging 40:1415–1425CrossRefPubMed Paspulati R, Partovi S, Herrmann K, et al. (2015) Comparison of hybrid FDG PET/MRI compared with PET/CT in colorectal cancer staging and restaging: a pilot study. Abdom Imaging 40:1415–1425CrossRefPubMed
25.
Zurück zum Zitat Brendle C, Schwenzer N, Rempp H, et al. (2016) Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series. Eur J Nucl Med Mol I 43:123–132CrossRef Brendle C, Schwenzer N, Rempp H, et al. (2016) Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series. Eur J Nucl Med Mol I 43:123–132CrossRef
26.
Zurück zum Zitat Lee S, Seo H, Kang K, et al. (2015) Clinical performance of whole-body 18F-FDG PET/dixon-VIBE, T1-weighted, and T2-weighted MRI protocol in colorectal cancer. Clin Nucl Med 40:e392CrossRefPubMed Lee S, Seo H, Kang K, et al. (2015) Clinical performance of whole-body 18F-FDG PET/dixon-VIBE, T1-weighted, and T2-weighted MRI protocol in colorectal cancer. Clin Nucl Med 40:e392CrossRefPubMed
27.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind C (2010) TNM classification of malignant tumours. Hoboken: Wiley Sobin LH, Gospodarowicz MK, Wittekind C (2010) TNM classification of malignant tumours. Hoboken: Wiley
28.
Zurück zum Zitat Rappeport E, Loft A, Berthelsen A, et al. (2007) Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation. Acta Radiol 48:369–378CrossRefPubMed Rappeport E, Loft A, Berthelsen A, et al. (2007) Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation. Acta Radiol 48:369–378CrossRefPubMed
29.
Zurück zum Zitat Kong G, Jackson C, Koh D, et al. (2008) The use of 18F-FDG PET/CT in colorectal liver metastases—comparison with CT and liver MRI. Eur J Nucl Med Mol I 35:1323–1329CrossRef Kong G, Jackson C, Koh D, et al. (2008) The use of 18F-FDG PET/CT in colorectal liver metastases—comparison with CT and liver MRI. Eur J Nucl Med Mol I 35:1323–1329CrossRef
30.
Zurück zum Zitat Michielsen K, Vergote I, Beeck K, et al. (2014) Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT. Eur Radiol 24:889–901CrossRefPubMed Michielsen K, Vergote I, Beeck K, et al. (2014) Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT. Eur Radiol 24:889–901CrossRefPubMed
31.
Zurück zum Zitat Antoch G, Vogt F, Freudenberg L, et al. (2003) Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 290:3199–3206CrossRefPubMed Antoch G, Vogt F, Freudenberg L, et al. (2003) Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 290:3199–3206CrossRefPubMed
32.
Zurück zum Zitat Schulthess G, Schlemmer H-P (2009) A look ahead: PET/MR versus PET/CT. Eur J Nucl Med Mol I 36:3–9CrossRef Schulthess G, Schlemmer H-P (2009) A look ahead: PET/MR versus PET/CT. Eur J Nucl Med Mol I 36:3–9CrossRef
33.
Zurück zum Zitat Boss A, Bisdas S, Kolb A, et al. (2010) Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT. J Nucl Med 51:1198–1205CrossRefPubMed Boss A, Bisdas S, Kolb A, et al. (2010) Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT. J Nucl Med 51:1198–1205CrossRefPubMed
34.
Zurück zum Zitat Delso G, Fürst S, Jakoby B, et al. (2011) Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med 52:1914–1922CrossRefPubMed Delso G, Fürst S, Jakoby B, et al. (2011) Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med 52:1914–1922CrossRefPubMed
35.
Zurück zum Zitat Chandarana H, Heacock L, Rakheja R, et al. (2013) Pulmonary nodules in patients with primary malignancy: comparison of hybrid PET/MR and PET/CT imaging. Radiology 268:874–881CrossRefPubMed Chandarana H, Heacock L, Rakheja R, et al. (2013) Pulmonary nodules in patients with primary malignancy: comparison of hybrid PET/MR and PET/CT imaging. Radiology 268:874–881CrossRefPubMed
36.
Zurück zum Zitat Chen Y, Huang G, Sun X, et al. (2008) Optimizing delayed scan time for FDG PET: comparison of the early and late delayed scan. Nucl Med Commun 29:425CrossRefPubMed Chen Y, Huang G, Sun X, et al. (2008) Optimizing delayed scan time for FDG PET: comparison of the early and late delayed scan. Nucl Med Commun 29:425CrossRefPubMed
37.
Zurück zum Zitat Laffon E, de Clermont H, Begueret H, et al. (2009) Assessment of dual-time-point 18F-FDG-PET imaging for pulmonary lesions. Nucl Med Commun 30:455CrossRefPubMed Laffon E, de Clermont H, Begueret H, et al. (2009) Assessment of dual-time-point 18F-FDG-PET imaging for pulmonary lesions. Nucl Med Commun 30:455CrossRefPubMed
38.
Zurück zum Zitat Cheng G, Torigian D, Zhuang H, Alavi A (2013) When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET? Eur J Nucl Med Mol I 40:779–787CrossRef Cheng G, Torigian D, Zhuang H, Alavi A (2013) When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET? Eur J Nucl Med Mol I 40:779–787CrossRef
Metadaten
Titel
Colorectal cancer staging: comparison of whole-body PET/CT and PET/MR
verfasst von
Onofrio A. Catalano
Artur M. Coutinho
Dushyant V. Sahani
Mark G. Vangel
Michael S. Gee
Peter F. Hahn
Thomas Witzel
Andrea Soricelli
Marco Salvatore
Ciprian Catana
Umar Mahmood
Bruce R. Rosen
Debra Gervais
Publikationsdatum
28.11.2016
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 4/2017
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0985-3

Weitere Artikel der Ausgabe 4/2017

Abdominal Radiology 4/2017 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.